Headlines

Oxygen-Enhanced MRI imaging company BIOXDYN has been shown to have potential in the early diagnosis of cancer

1 December 2015
The technique was pioneered by Prof Geoff Parker at the University of Manchester, patented and then spun-out into Bioxydyn.
Read

Metaldehyde successfully removed to below UK/ EU limits

1 December 2015
Newly published paper on metaldehyde in water shows MTI Investee Arvia Technology removes the pesticide to residual concentrations well below EU/UK regulatory limits of 0.1 μg/L.
Read

Bioxydyn's key role in generation of paper in the journal Radiology that describes the use of quantitative MRI methods to characterise lung density changes in COPD

1 December 2015
The paper, which involved collaborative between the University of Manchester and AstraZeneca, shows that the information on lung density that can be provided using MRI is equivalent to that available from CT, but without the ionising radiation burden.  
Read

MTI Investee EXOSECT - Optimising the delivery of synthetic and biological chemistry offers the post-harvest storage sector new possibilities

1 July 2015
The 10th Conference of the IOBC Working Group on the Integrated Protection of Stored Products was held in Zagreb last month.
Read

MTI Investee OXFORD PV - Perovskite Solar Cells Could Beat the Efficiency of Silicon

1 July 2015
An upstart material—perovskite—could finally make solar cells that are cheaper and more efficient than the prevailing silicon technology
Read

MTI Investee EXOSECT: How sexually confusing moths could save your clothes from holes!

1 June 2015
Museum tricks male moths into thinking other males are females in bid to stop them reproducing as it wages gender warfare on cloth-eating insects.
Read

MTI Investee EXOSECT'S proprietary platform technology successfully delivers pesticide at fifty percent reduction in concentration, research shows

1 June 2015
Exosect Ltd., a leading provider of enabling technologies, today announced that Exosect’s Research Scientist, Freya Scoates, will be presenting key data on the successful delivery of deltamethrin and pirimiphos-methyl formulations at rates half that of conventional formulations, by using the Entostat platform.
Read

MTI Investee FUEL3D Signs Funding Agreement With In-Q-Tel To Refine Their Scanners for the Intelligence Community

1 May 2015
Fuel3D just signed a strategic investment and technology development agreement with In-Q-Tel (IQT), a not-for-profit investment firm that identifies innovative technology solutions to support the missions of the U.S. Intelligence Community.
Read